COVID-19-associated alopecia: Difference between revisions
Jose Loyola (talk | contribs) |
Jose Loyola (talk | contribs) |
||
| Line 12: | Line 12: | ||
==Overview== | ==Overview== | ||
*[[COVID-19]] has been associated with [[alopecia]]. The [[pathophysiology]] mechanism is unknown. | *[[COVID-19]] has been associated with [[alopecia]]. The [[pathophysiology]] mechanism is unknown. | ||
==Alopecia== | |||
===Mechanism=== | |||
====Complications==== | |||
Revision as of 23:02, 14 October 2021
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19-associated alopecia On the Web |
|
American Roentgen Ray Society Images of COVID-19-associated alopecia |
|
Risk calculators and risk factors for COVID-19-associated alopecia |
For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]
Synonyms and keywords: COVID-19-associated exanthematous rash; COVID-19-associated livedo reticularis; COVID-19-associated livedoid lesions; COVID-19-associated multisystem inflammatory syndrome in children; COVID-19-associated retiform purpura; COVID-19-associated urticaria; COVID-19-associated vasculitis; COVID-19-associated vesicular eruptions
Overview
- COVID-19 has been associated with alopecia. The pathophysiology mechanism is unknown.